All of the following are true about the recent epidemiologic transition in the United State EXCEPT

The second epidemiological transition, as first described by Omran (1971), has meant that death as a relatively acute event due to infectious disease has to a great extent been transformed into a death typified by protracted ailments (Illich, 1975), for instance as a result of cancer, cardiovascular disease, or in people living to a very old age by multiorgan failure toward the end of life.

From: International Encyclopedia of Public Health (Second Edition), 2017

  1. Omran AR. The epidemiologic transition. A theory of the epidemiology of population change. Milbank Mem Fund Q. 1971;49:509–38.

    CAS  Article  PubMed  Google Scholar 

  2. Alexandersson G. The demographic transition: model and reality. Fennia. 1981;159:35–42.

    CAS  PubMed  Google Scholar 

  3. Mackenbach JP. The epidemiologic transition theory. J Epidemiol Community Health. 1994;48:329–31.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  4. Santosa A, Wall S, Fottrell E, Hogberg U, Byass P. The development and experience of epidemiological transition theory over four decades: a systematic review. Glob Health Action. 2014;7:23574.

    Article  Google Scholar 

  5. Carson C, Hajat S, Armstrong B, Wilkinson P. Declining vulnerability to temperature-related mortality in London over the 20th century. Am J Epidemiol. 2006;164:77–84.

    Article  PubMed  Google Scholar 

  6. Wild SH, Fischbacher C, Brock A, Griffiths C, Bhopal R. Mortality from all causes and circulatory disease by country of birth in England and Wales 2001–2003. J Public Health (Oxf). 2007;29:191–8.

    CAS  Article  Google Scholar 

  7. Weden MM, Brown RA. Historical and life course timing of the male mortality disadvantage in Europe: epidemiologic transitions, evolution, and behavior. Soc Biol. 2006;53:61–80.

    PubMed  Google Scholar 

  8. Gulliford MC. Epidemiological transition in Trinidad and Tobago, west indies 1953 to 1992. Int J Epidemiol. 1996;25:357–65.

    CAS  Article  PubMed  Google Scholar 

  9. Kuate Defo B. Demographic, epidemiological, and health transitions: are they relevant to population health patterns in Africa? Glob Health Action. 2014;2014:7.

  10. Olshansky SJ, Ault AB. The fourth stage of the epidemiologic transition: the age of delayed degenerative diseases. Milbank Q. 1986;64:355–91.

    CAS  Article  PubMed  Google Scholar 

  11. Modig K, Andersson T, Drefahl S, Ahlbom A. Age-specific trends in morbidity, mortality and case-fatality from cardiovascular disease. Myocardial infarction and stroke in advanced Age: evaluation in the Swedish population. PLoS One. 2013;8:e64928.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  12. Omran AR. The epidemiologic transition: a theory of the epidemiology of population change. Milbank Q. 2005;83:731–57.

    Article  PubMed  PubMed Central  Google Scholar 

  13. World Health Organization. World Report on Ageing and Health. Geneva: WHO Press; 2015.

  14. Wellcome Trust. Frontiers Meeting on the Use of Electronic Patient Records for Research and Health Benefit. 2016: 2007. http://docplayer.net/1818277-Frontiers-meeting-use-of-electronic.html.

  15. Herrett E, Gallagher AM, Bhaskaran K, Forbes H, Mathur R, van Staa T, Smeeth L. Data resource profile: clinical practice research datalink (CPRD). Int J Epidemiol. 2015;44:827–36.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Williams T, van Staa T, Puri S, Eaton S. Recent advances in the utility and use of the general practice research database as an example of a UK primary care data resource. Ther Adv Drug Safety. 2012;3:89–99.

    Article  Google Scholar 

  17. Mathur R, Bhaskaran K, Chaturvedi N, Leon DA, van Staa T, Grundy E, Smeeth L. Completeness and usability of ethnicity data in UK-based primary care and hospital databases. J Public Health (Oxf). 2014;36:684–92.

    Article  Google Scholar 

  18. Quint JK, Millett ERC, Joshi M, Navaratnam V, Thomas SL, Hurst JR, Smeeth L, Brown JS. Changes in the incidence, prevalence and mortality of bronchiectasis in the UK from 2004–2013: a population based cohort study. Eur Respir J. 2016;47:186–93.

    Article  PubMed  Google Scholar 

  19. Bhattarai N, Charlton J, Rudisill C, Gulliford MC. Coding, recording and incidence of different forms of coronary heart disease in primary care. PLoS One. 2012;7:e29776.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  20. Gulliford MCJ, Ashworth M, Rudd AG, Toschke AM, for the eCRT Research Team. Selection of medical diagnostic codes for analysis of electronic patient records. Application to stroke in a primary care database. PLoS One. 2009;4(9):1-10. e7168.

  21. Hamada S, Gulliford MC. Mortality in type 2 diabetes at 80 years or older in relation to HbA1c, blood pressure, and total cholesterol. J Am Geriatr Soc. 2016;64(7):1425–31.

    Article  PubMed  Google Scholar 

  22. Hazra NC, Dregan A, Jackson S, Gulliford MC. Differences in health at Age 100 according to Sex: population-based cohort study of centenarians using electronic health records. J Am Geriatr Soc. 2015;63:1331–7.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Noordzij M, Leffondré K, van Stralen KJ, Zoccali C, Dekker FW, Jager KJ. When do we need competing risks methods for survival analysis in nephrology? Nephrol Dial Transplant. 2013;28(11):2670–7.

    Article  PubMed  Google Scholar 

  24. Austin PC, Lee DS, Fine JP. Introduction to the analysis of survival data in the presence of competing risks. Circulation. 2016;133:601.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Rockwood K, Andrew M, Mitnitski A. A comparison of two approaches to measuring frailty in elderly people. J Gerontol A Biol Sci Med Sci. 2007;62:738–43.

    Article  PubMed  Google Scholar 

  26. Bajekal M, Scholes S, Love H, Hawkins N, O'Flaherty M, Raine R, Capewell S. Analysing recent socioeconomic trends in coronary heart disease mortality in England, 2000–2007: a population modelling study. PLoS Med. 2012;9:e1001237.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Bajekal M, Scholes S, O’Flaherty M, Raine R, Norman P, Capewell S. Unequal trends in coronary heart disease mortality by socioeconomic circumstances, England 1982–2006: an analytical study. PLoS One. 2013;8:e59608.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  28. Lee S, Shafe ACE, Cowie MR. UK stroke incidence, mortality and cardiovascular risk management 1999–2008: time-trend analysis from the General Practice Research Database. BMJ Open. 2011;1(2):e000269.

  29. Kuulasmaa K, Tunstall-Pedoe H, Dobson A, Fortmann S, Sans S, Tolonen H, Evans A, Ferrario M, Tuomilehto J. Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project populations. Lancet. 2000;355:675–87.

    CAS  Article  PubMed  Google Scholar 

  30. Alageel S, Wright AJ, Gulliford MC. Changes in cardiovascular disease risk and behavioural risk factors before the introduction of a health check programme in England. Prev Med. 2016;91:158–63.

    Article  PubMed  Google Scholar 

  31. Dregan A, Ravindrarajah R, Hazra N, Hamada S, Jackson SH, Gulliford MC. Longitudinal trends in hypertension management and mortality among octogenarians: prospective cohort study. Hypertension. 2016;68:97–105.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  32. Falaschetti E, Mindell J, Knott C, Poulter N. Hypertension management in England: a serial cross-sectional study from 1994 to 2011. Lancet. 2014;383:1912–9.

    Article  PubMed  Google Scholar 

  33. Loopstra R, McKee M, Katikireddi SV, Taylor-Robinson D, Barr B, Stuckler D. Austerity and old-age mortality in England: a longitudinal cross-local area analysis, 2007–2013. J R Soc Med. 2016;109:109–16.

    Article  PubMed  PubMed Central  Google Scholar 

  34. American Lung Association. Trends in COPD (Chronic Bronchitis and Emphysema): Morbidity and Mortality. Epidemiology and Statistics Unit, Research and Health Education Division. 2013.

  35. Akushevich I, Kravchenko J, Ukraintseva S, Arbeev K, Yashin AI. Time trends of incidence of age-associated diseases in the US elderly population: Medicare-based analysis. Age Ageing. 2013;42:494–500.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Simpson CR, Hippisley-Cox J, Sheikh A. Trends in the epidemiology of chronic obstructive pulmonary disease in England: a national study of 51 804 patients. Br J Gen Pract. 2010;60:e277–84.

    Article  PubMed Central  Google Scholar 

  37. NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants. Lancet. 2016;387:1513–30.

    Article  Google Scholar 

  38. Centers for Disease Control and Prevention: Crude and Age-Adjusted Rates of Diagnosed Diabetes per 100 Civilian, Non-Institutionalized Population, United States, 1980-2014. 2015.

  39. NCD Risk Factor Collaboration (NCD-RisC). Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19.2 million participants. Lancet. 2016;387:1377–96.

    Article  Google Scholar 

  40. Abraham TM, Pencina KM, Pencina MJ, Fox CS. Trends in diabetes incidence: the Framingham heart study. Diabetes Care. 2015;38:482–7.

    Article  PubMed  Google Scholar 

  41. Cancer Incidence by age. 2016. [http://www.cancerresearchuk.org/health-professional/cancer-statistics/incidence/age#heading-Four] Accessed 5 Sept 2016.

  42. Wu Y-T, Fratiglioni L, Matthews FE, Lobo A, Breteler MMB, Skoog I, Brayne C. Dementia in western Europe: epidemiological evidence and implications for policy making. Lancet Neurol. 2015;15(1):116–24.

    Article  PubMed  Google Scholar 

  43. Hazra NC, Dregan A, Jackson S, Gulliford MC. Drug utilization and inappropriate prescribing in centenarians. J Am Geriatr Soc. 2016;64:1079–84.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Campese V, Schneider EL. Reevaluating the use of antihypertensive medications, a first step toward reducing polypharmacy in very old patients. J Clin Hypertens (Greenwich). 2010;12:621–4.

    Article  Google Scholar 

  45. International Longevity Centre (ILC-UK). The state of the nation’s housing. 2016. http://www.ilcuk.org.uk/index.php/publications/publication_details/the_state_of_the_nations_housing_an_ilc_uk_factpack.

  46. Health and Social Care Information Centre. Attribution Data Set GP-Registered Populations Scaled to ONS Population Estimates - 2011. Published Feb 2, 2012. http://content.digital.nhs.uk/pubs/gpregpop11.

  47. Herrett EL, Thomas SL, Smeeth L. Validity of diagnoses in the general practice research database. Br J Gen Pract. 2011;61:438–9.

    Article  PubMed  PubMed Central  Google Scholar 

  48. Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet. 2012;380(9836):37–43.

    Article  PubMed  Google Scholar 


Page 2

Period Total population 80+ years per thousand total population (95% CI) Female population 80+ years per thousand total population (95% CI) Male population 80+ years per thousand total population (95% CI)
80+ years All ages (millions) 80+ years All ages (millions) 80+ years All ages (millions)
1990-1994 53,008 1.16 45.7 (45.3 to 46.1) 36,533 0.59 61.0 (61.2 to 62.5) 16,475 0.57 28.9 (28.5 to 29.4)
1995-1999 96,266 2.06 46.7 (46.4 to 47.0) 65,649 1.04 62.9 (62.4 to 63.4) 30,617 1.02 30.1 (29.8 to 30.4)
2000-2004 195,829 4.03 48.5 (48.3 to 48.8) 130,126 2.03 64.0 (63.7 to 64.4) 65,703 2.00 32.8 (32.6 to 33.1)
2005-2009 235,745 4.77 49.4 (49.2 to 49.6) 152,266 2.40 63.5 (63.2 to 63.8) 83.479 2.37 35.2 (35.0 to 35.4)
2010-2014 226,479 4.45 50.9 (50.7 to 51.1) 141,359 2.24 63.0 (62.7 to 63.3) 85,119 2.20 38.6 (38.4 to 38.9)

  1. Figures are means of annual mid-year counts for each period, except where indicated
  2. CI, confidence interval; CPRD, Clinical Practice Research Datalink